MiR-101-3p and miR-195 were found to be putative targets of SNHG12, which inhibited the progression of glioma by down-regulating their target genes, Forkhead Box Protein P1 (FOXP1), and Sry-Box 5 (SOX5) (12, 26). This evidence concerns the gene SOX5 and glioma.